Cargando…
Circulating endothelial cells in oncology: pitfalls and promises
Adequate blood supply is a prerequisite in the pathogenesis of solid malignancies. As a result, depriving a tumour from its oxygen and nutrients, either by preventing the formation of new vessels, or by disrupting vessels already present in the tumour, appears to be an effective treatment modality i...
Autores principales: | Strijbos, M H, Gratama, J W, Kraan, J, Lamers, C H, Bakker, MA den, Sleijfer, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410112/ https://www.ncbi.nlm.nih.gov/pubmed/18506173 http://dx.doi.org/10.1038/sj.bjc.6604383 |
Ejemplares similares
-
Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
por: Kraan, J, et al.
Publicado: (2014) -
Pitfalls and promises of bile duct alternatives: A narrative review
por: Miyazawa, Mitsuo, et al.
Publicado: (2022) -
Circulating endothelial progenitor cells
por: Garmy-Susini, B, et al.
Publicado: (2005) -
Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases
por: Lalmahomed, Z S, et al.
Publicado: (2015) -
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial
por: Beije, N, et al.
Publicado: (2015)